iShares U.S. Pharmaceuticals ETF (IHE) Chart & Stock Price History $70.72 -0.32 (-0.45%) Closing price 04:10 PM EasternExtended Trading$70.74 +0.03 (+0.04%) As of 06:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock iShares U.S. Pharmaceuticals ETF Stock Price Performance The iShares U.S. Pharmaceuticals ETF (IHE) fund chart highlights key performance trends across multiple timeframes. Over the last 12 months, the fund's price has decreased 1.93%, with a year-to-date return of 7.61%. In the past month, the fund has increased 3.02%, reflecting recent market activity. As of the latest close, iShares U.S. Pharmaceuticals ETF traded at $71.04 with a market cap of $582.53 million and volume of 38,186 shares. Five years ago, the fund traded at a split-adjusted price of $55.43, representing a 27.58% increase over that period. At the time, it had a market cap of $351.26 million and a volume of 8,232 shares. Receive IHE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-0.38%1 Month Performance+3.02%3 Month Performance+10.52%Year-To-Date Performance+7.61%1 Year Performance-1.93%5 Year Performance+27.58% IHE Stock Chart for Thursday, August, 28, 2025 IHE Chart by TradingView iShares U.S. Pharmaceuticals ETF Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/28/2025$71.04$70.72-0.45%$71.05$70.5433,410 shs$579.90 million08/27/2025$70.92$71.04+0.17%$71.50$70.9438,186 shs$582.53 million08/26/2025$70.04$70.92+1.26%$70.97$70.2518,308 shs$581.54 million08/25/2025$70.99$70.04-1.34%$71.01$70.0120,567 shs$574.33 million08/22/2025$70.54$70.99+0.64%$71.40$70.8154,779 shs$582.12 million08/21/2025$70.19$70.54+0.50%$70.88$69.8059,164 shs$578.43 million08/20/2025$69.83$70.19+0.52%$70.24$69.7620,800 shs$575.56 million08/19/2025$69.50$69.83+0.47%$70.19$69.6524,908 shs$572.61 million08/18/2025$69.67$69.50-0.24%$70.07$69.4928,258 shs$569.90 million08/15/2025$69.10$69.67+0.82%$69.94$69.1222,762 shs$571.29 million Get the Latest News and Ratings for IHE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. 08/14/2025$68.43$69.10+0.98%$69.11$67.9117,977 shs$566.62 million08/13/2025$67.00$68.43+2.13%$68.50$67.1527,060 shs$561.13 million08/12/2025$66.38$67.00+0.93%$67.00$66.5057,957 shs$549.40 million08/11/2025$66.06$66.38+0.48%$66.93$66.2325,665 shs$552.64 million08/08/2025$65.74$66.06+0.49%$66.23$65.6042,503 shs$541.69 million08/07/2025$66.77$65.74-1.54%$66.10$64.9473,323 shs$539.07 million08/06/2025$67.73$66.77-1.42%$67.16$66.6220,835 shs$547.51 million08/05/2025$67.94$67.73-0.31%$67.98$67.3846,729 shs$555.39 million08/04/2025$66.79$67.94+1.72%$67.94$66.5620,320 shs$557.11 million08/01/2025$65.75$66.79+1.58%$66.89$65.6341,614 shs$547.68 million07/31/2025$67.29$65.75-2.29%$67.22$65.5439,280 shs$539.15 million07/30/2025$67.70$67.29-0.61%$68.21$67.1053,735 shs$551.78 million07/29/2025$68.65$67.70-1.38%$68.04$67.6058,483 shs$555.14 million07/28/2025$69.27$68.65-0.90%$69.22$68.3224,601 shs$562.93 million Related Companies PPH Stock Chart LABU Stock Chart RSPH Stock Chart IHF Stock Chart BBH Stock Chart PJP Stock Chart FXH Stock Chart PBE Stock Chart CURE Stock Chart XPH Stock Chart Receive IHE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:IHE) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access